P3 Health Partners (PIII) Competitors $8.82 -0.05 (-0.51%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PIII vs. DCGO, TOI, CORBF, AIRS, XGN, ATPC, SERA, EUDA, QIPT, and BDSXShould you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include DocGo (DCGO), Oncology Institute (TOI), Global Cord Blood (CORBF), AirSculpt Technologies (AIRS), Exagen (XGN), Agape ATP (ATPC), Sera Prognostics (SERA), EUDA Health (EUDA), Quipt Home Medical (QIPT), and Biodesix (BDSX). These companies are all part of the "healthcare" industry. P3 Health Partners vs. DocGo Oncology Institute Global Cord Blood AirSculpt Technologies Exagen Agape ATP Sera Prognostics EUDA Health Quipt Home Medical Biodesix DocGo (NASDAQ:DCGO) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations, profitability and community ranking. Do analysts recommend DCGO or PIII? DocGo presently has a consensus target price of $4.89, suggesting a potential upside of 112.22%. P3 Health Partners has a consensus target price of $16.25, suggesting a potential upside of 87.97%. Given DocGo's stronger consensus rating and higher probable upside, research analysts plainly believe DocGo is more favorable than P3 Health Partners.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83P3 Health Partners 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do insiders & institutionals have more ownership in DCGO or PIII? 56.4% of DocGo shares are owned by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are owned by institutional investors. 2.7% of DocGo shares are owned by insiders. Comparatively, 15.8% of P3 Health Partners shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in DCGO or PIII? DocGo received 43 more outperform votes than P3 Health Partners when rated by MarketBeat users. Likewise, 75.00% of users gave DocGo an outperform vote while only 31.25% of users gave P3 Health Partners an outperform vote. CompanyUnderperformOutperformDocGoOutperform Votes4875.00% Underperform Votes1625.00% P3 Health PartnersOutperform Votes531.25% Underperform Votes1168.75% Does the media refer more to DCGO or PIII? In the previous week, DocGo had 1 more articles in the media than P3 Health Partners. MarketBeat recorded 4 mentions for DocGo and 3 mentions for P3 Health Partners. P3 Health Partners' average media sentiment score of 1.58 beat DocGo's score of 1.37 indicating that P3 Health Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive P3 Health Partners 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is DCGO or PIII more profitable? DocGo has a net margin of 4.35% compared to P3 Health Partners' net margin of -6.95%. DocGo's return on equity of 8.90% beat P3 Health Partners' return on equity.Company Net Margins Return on Equity Return on Assets DocGo4.35% 8.90% 5.72% P3 Health Partners -6.95%-71.31%-11.93% Which has preferable earnings & valuation, DCGO or PIII? DocGo has higher earnings, but lower revenue than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDocGo$616.56M0.38$6.86M$0.1713.56P3 Health Partners$1.50B0.04-$57.77M-$49.00-0.18 Which has more volatility and risk, DCGO or PIII? DocGo has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. SummaryDocGo beats P3 Health Partners on 15 of the 18 factors compared between the two stocks. Get P3 Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for PIII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PIII vs. The Competition Export to ExcelMetricP3 Health PartnersHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$63.20M$850.75M$5.55B$8.04BDividend YieldN/A2.55%5.09%4.22%P/E Ratio-10.4853.9522.6818.83Price / Sales0.047.39404.28106.72Price / Cash2.3226.1438.1834.62Price / Book19.564.026.794.33Net Income-$57.77M-$5.50M$3.22B$247.97M7 Day Performance-1.57%-0.77%2.44%2.71%1 Month Performance-4.03%3.86%3.78%3.37%1 Year Performance-70.66%22.02%17.05%5.80% P3 Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PIIIP3 Health Partners2.7409 of 5 stars$8.80-0.8%$16.25+84.7%-69.3%$63.20M$1.50B-10.48500Upcoming EarningsPositive NewsGap UpDCGODocGo2.3762 of 5 stars$2.24flat$4.89+118.4%-35.1%$228.44M$616.56M8.002,920Upcoming EarningsPositive NewsTOIOncology Institute0.6901 of 5 stars$2.91-12.1%N/A+149.1%$219.88M$393.41M-3.73660News CoverageHigh Trading VolumeCORBFGlobal Cord BloodN/A$1.05+10.5%N/AN/A$127.63M$196.12M0.001,200Gap UpAIRSAirSculpt Technologies0.9651 of 5 stars$2.11+7.7%$3.75+77.7%-59.0%$123.59M$180.35M-15.07240News CoverageGap UpXGNExagen4.0947 of 5 stars$6.65+7.1%$7.50+12.8%+351.5%$119.02M$55.64M-7.07220Positive NewsGap UpHigh Trading VolumeATPCAgape ATP0.3253 of 5 stars$2.38+7.7%N/A-60.9%$119.01M$1.32M-3.2640SERASera Prognostics1.0641 of 5 stars$3.00-5.1%N/A-71.9%$112.99M$77,000.00-3.03120Short Interest ↓News CoverageEUDAEUDA Health1.1096 of 5 stars$3.74-2.3%N/A+99.6%$92.11M$3.81M0.002Upcoming EarningsNews CoverageGap DownQIPTQuipt Home Medical2.1582 of 5 stars$2.12+1.0%$6.25+194.8%-41.4%$91.35M$244.72M-12.47800Positive NewsBDSXBiodesix3.2783 of 5 stars$0.57+5.8%$2.95+417.5%-57.9%$83.47M$71.32M-1.46220Upcoming EarningsAnalyst ForecastNews Coverage Related Companies and Tools Related Companies DCGO Competitors TOI Competitors CORBF Competitors AIRS Competitors XGN Competitors ATPC Competitors SERA Competitors EUDA Competitors QIPT Competitors BDSX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PIII) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PIII Stock Free PIII Stock Alerts